Detalhe da pesquisa
1.
9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial.
Br J Haematol
; 196(1): 116-126, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34520052
2.
Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i).
Br J Haematol
; 196(3): 606-616, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34775591
3.
Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1.
Blood
; 136(25): 2851-2863, 2020 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33113552
4.
Bendamustine, followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia (CLL2-BIO): primary endpoint analysis of a multicenter, open-label phase-II trial.
Haematologica
; 106(2): 543-554, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107341
5.
Voluntary pursuit of negatively valenced stimuli from childhood to early adulthood.
Dev Sci
; 24(2): e13012, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32615010
6.
Balancing risk and benefit in early-stage classical Hodgkin lymphoma.
Blood
; 131(15): 1666-1678, 2018 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29500174
7.
Dissecting "Peer Presence" and "Decisions" to Deepen Understanding of Peer Influence on Adolescent Risky Choice.
Child Dev
; 90(6): 2086-2103, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29701282
8.
The Nonlinear Development of Emotion Differentiation: Granular Emotional Experience Is Low in Adolescence.
Psychol Sci
; 29(8): 1346-1357, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29878880
9.
A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma.
Blood
; 125(26): 4024-31, 2015 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25887777
10.
The emerging role of immune checkpoint inhibition in malignant lymphoma.
Haematologica
; 102(1): 30-42, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27884973
11.
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
Lancet
; 385(9976): 1418-27, 2015 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25539730
12.
Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group.
Blood
; 123(11): 1658-64, 2014 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24478403
13.
Brentuximab vedotin for relapsed or refractory CD30+ hematologic malignancies: the German Hodgkin Study Group experience.
Blood
; 120(7): 1470-2, 2012 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-22786877
14.
Programmed cell death protein-1 (PD-1)-expression in the microenvironment of classical Hodgkin lymphoma at relapse during anti-PD-1-treatment.
Haematologica
; 104(1): e21-e24, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30076177
15.
Programmed cell death protein1 (PD1)-expression in the microenvironment of classical Hodgkin lymphoma at relapse after conventional chemotherapy and at relapse on anti-PD1 treatment.
Haematologica
; 104(1): e45-e46, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30598497
16.
Venetoclax plus rituximab or obinutuzumab after allogeneic hematopoietic stem cell transplantation in chronic lymphocytic leukemia.
Haematologica
; 104(5): e224-e226, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30792201
17.
Leucocyte and eosinophil counts predict progression-free survival in relapsed or refractory classical Hodgkin Lymphoma patients treated with PD1 inhibition.
Br J Haematol
; 181(6): 837-840, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28439879
18.
AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trial.
Leuk Lymphoma
; 63(8): 1871-1878, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35848865
19.
Reverted exhaustion phenotype of circulating lymphocytes as immune correlate of anti-PD1 first-line treatment in Hodgkin lymphoma.
Leukemia
; 36(3): 760-771, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34584203
20.
Hodgkin Lymphoma-Review on Pathogenesis, Diagnosis, Current and Future Treatment Approaches for Adult Patients.
J Clin Med
; 10(5)2021 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33800409